Sinus Headache — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for sinus headache. 17 active patents protecting 2 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
17
Active US patents
66/100
Avg vulnerability
Annual revenue covered

Originators in Sinus Headache

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Boots Group) 17 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating sinus headache. Each bar = one year. Y-axis scaled to peak year (8 patents).

8
29
2
30
4
32
3
35

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Advil
ibuprofen
Generic (originally Boots Group) 14 70 2029-09-30
Mucinex
guaifenesin
Generic (multiple manufacturers) 3 62 2035-11-13

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11806400 Advil method of use 76 2032-03-16
11806400 Advil method of use 76 2032-03-16
8871810 Advil method of use 73 2029-09-30
8735452 Advil method of use 73 2029-09-30
9295639 Advil method of use 68 2029-09-30
8735452 Advil method of use 68 2029-09-30
9138404 Advil method of use 68 2029-09-30
9114068 Advil method of use 68 2029-09-30
9649284 Advil method of use 68 2029-09-30
8871810 Advil method of use 68 2029-09-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9549907 Mucinex method of use 62 2035-11-13
10105324 Mucinex method of use 62 2035-11-13
9808431 Mucinex method of use 62 2035-11-13
9072661 Advil method of use 68 2032-03-16
9072710 Advil method of use 68 2032-03-16
9012508 Advil method of use 68 2030-09-14
9012508 Advil method of use 68 2030-09-14
9295639 Advil method of use 68 2029-09-30
8735452 Advil method of use 68 2029-09-30
9138404 Advil method of use 68 2029-09-30

Related